These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11978526)

  • 21. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
    Posner MC; Niedzwiecki D; Venook AP; Hollis DR; Kindler HL; Martin EW; Schilsky RL; Goldberg RM; Mayer RJ
    Ann Surg Oncol; 2008 Jan; 15(1):158-64. PubMed ID: 18008108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates.
    Guo M; You C; Dou J
    Biomed Pharmacother; 2018 Nov; 107():1318-1325. PubMed ID: 30257347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of colorectal cancer: new perspectives after a long path.
    Correale P; Botta C; Ciliberto D; Pastina P; Ingargiola R; Zappavigna S; Tassone P; Pirtoli L; Caraglia M; Tagliaferri P
    Immunotherapy; 2016 Nov; 8(11):1281-1292. PubMed ID: 27993089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mimicry of carcinoembryonic antigen by peptides derived from the structure of an anti-idiotype antibody.
    Chatterjee SK; Tripathi PK; Chakraborty M; Yannelli J; Wang H; Foon KA; Maier CC; Blalock JE; Bhattacharya-Chatterjee M
    Cancer Res; 1998 Mar; 58(6):1217-24. PubMed ID: 9515808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody.
    Robins RA; Denton GW; Hardcastle JD; Austin EB; Baldwin RW; Durrant LG
    Cancer Res; 1991 Oct; 51(19):5425-9. PubMed ID: 1913661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody.
    Denton GW; Durrant LG; Hardcastle JD; Austin EB; Sewell HF; Robins RA
    Int J Cancer; 1994 Apr; 57(1):10-4. PubMed ID: 8150527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotherapy for colorectal cancer.
    Maxwell-Armstrong CA; Durrant LG; Scholefield JH
    Am J Surg; 1999 Apr; 177(4):344-8. PubMed ID: 10326858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An idiotypic replica of carcinoembryonic antigen inducing cellular and humoral responses directed against human colorectal tumours.
    Durrant LG; Denton GW; Jacobs E; Mee M; Moss R; Austin EB; Baldwin RW; Hardcastle JD; Robins RA
    Int J Cancer; 1992 Mar; 50(5):811-6. PubMed ID: 1544714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotherapy for the Treatment of Urothelial Carcinoma.
    Donin NM; Lenis AT; Holden S; Drakaki A; Pantuck A; Belldegrun A; Chamie K
    J Urol; 2017 Jan; 197(1):14-22. PubMed ID: 27460757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.
    Ullenhag GJ; Frödin JE; Jeddi-Tehrani M; Lidströmer N; Strigård K; Eriksson E; Samanci A; Choudhury A; Nilsson B; Rossmann ED; Mosolits S; Mellstedt H
    Clin Cancer Res; 2004 May; 10(10):3273-81. PubMed ID: 15161680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiotypic antibody immunotherapy of cancer.
    Chatterjee MB; Foon KA; Köhler H
    Cancer Immunol Immunother; 1994 Feb; 38(2):75-82. PubMed ID: 8306369
    [No Abstract]   [Full Text] [Related]  

  • 32. Colorectal cancer vaccines: antiidiotypic antibody, recombinant protein, and viral vector.
    Basak S; Eck S; Gutzmer R; Smith AJ; Birebent B; Purev E; Staib L; Somasundaram R; Zaloudik J; Li W; Jacob L; Mitchell E; Speicher D; Herlyn D
    Ann N Y Acad Sci; 2000 Jun; 910():237-52; discussion 252-3. PubMed ID: 10911917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of CD4(+) and CD8(+) Bordetella pertussis toxin subunit S1 specific T cells by immunization with synthetic peptides.
    Fagerberg J; Askelöf P; Wigzell H; Mellstedt H
    Cell Immunol; 1999 Sep; 196(2):110-21. PubMed ID: 10527563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy and immunoescape in colorectal cancer.
    Mazzolini G; Murillo O; Atorrasagasti C; Dubrot J; Tirapu I; Rizzo M; Arina A; Alfaro C; Azpilicueta A; Berasain C; Perez-Gracia JL; Gonzalez A; Melero I
    World J Gastroenterol; 2007 Nov; 13(44):5822-31. PubMed ID: 17990348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CD133high Colorectal Cancer Cells In Vitro and In Vivo With an Asymmetric Bispecific Antibody.
    Zhao L; Yang Y; Zhou P; Ma H; Zhao X; He X; Wang T; Zhang J; Liu Y; Zhang T
    J Immunother; 2015; 38(6):217-28. PubMed ID: 26049545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients.
    Mosolits S; Markovic K; Frödin JE; Virving L; Magnusson CG; Steinitz M; Fagerberg J; Mellstedt H
    Clin Cancer Res; 2004 Aug; 10(16):5391-402. PubMed ID: 15328177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer.
    Nagorsen D; Thiel E
    Clin Cancer Res; 2006 May; 12(10):3064-9. PubMed ID: 16707603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment.
    Liu KJ; Chao TY; Chang JY; Cheng AL; Ch'ang HJ; Kao WY; Wu YC; Yu WL; Chung TR; Whang-Peng J
    J Biomed Sci; 2016 Aug; 23(1):64. PubMed ID: 27558635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a DNA vaccine encoding carcinoembryonic antigen and hepatitis B surface antigen in colorectal carcinoma patients.
    Conry RM; Curiel DT; Strong TV; Moore SE; Allen KO; Barlow DL; Shaw DR; LoBuglio AF
    Clin Cancer Res; 2002 Sep; 8(9):2782-7. PubMed ID: 12231517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.